Search research articles
Contact Us
Filters
Showing results (161-170 of 293) with videos related to
Page
of 30
Sort By:
AIDS (London, England)
|
March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
Gail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
HIV Medicine
|
February 26, 2015
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
G V Matthews, J Neuhaus, S Bhagani, et al.
The American Journal of Cardiology
|
January 8, 2014
Predictors of reperfusion delay in patients with ST elevation myocardial infarction self-transported to the hospital (from the American Heart Association's Mission: Lifeline Program)
David M Shavelle, Anita Y Chen, Ray V Matthews, et al.
Circulation
|
January 1, 1995
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
R A Kloner, T Shook, K Przyklenk, et al.
American Journal of Epidemiology
|
June 1, 1978
A comparison of dietary methods in epidemiologic studies
R W Morgan, M Jain, A B Miller, et al.
American Journal of Epidemiology
|
June 1, 1978
A study of diet and breast cancer
A B Miller, A Kelly, N W Choi, et al.
American Journal of Epidemiology
|
June 1, 1978
An epidemiologic study of breast cancer
N W Choi, G R Howe, A B Miller, et al.
Antiviral Therapy
|
September 14, 2010
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand
Anchalee Avihingsanon, Sharon R Lewin, Stephen Kerr, et al.
AIDS (London, England)
|
November 16, 2010
Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression
David M Iser, Anchalee Avihingsanon, Naruemon Wisedopas, et al.
Hepatology (Baltimore, Md.)
|
September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study
Marianne Martinello, Edward Gane, Margaret Hellard, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 293) with videos related to
Sort By:
Page
of 30
AIDS (London, England)
|
March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
Gail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
HIV Medicine
|
February 26, 2015
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
G V Matthews, J Neuhaus, S Bhagani, et al.
The American Journal of Cardiology
|
January 8, 2014
Predictors of reperfusion delay in patients with ST elevation myocardial infarction self-transported to the hospital (from the American Heart Association's Mission: Lifeline Program)
David M Shavelle, Anita Y Chen, Ray V Matthews, et al.
Circulation
|
January 1, 1995
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
R A Kloner, T Shook, K Przyklenk, et al.
American Journal of Epidemiology
|
June 1, 1978
A comparison of dietary methods in epidemiologic studies
R W Morgan, M Jain, A B Miller, et al.
American Journal of Epidemiology
|
June 1, 1978
A study of diet and breast cancer
A B Miller, A Kelly, N W Choi, et al.
American Journal of Epidemiology
|
June 1, 1978
An epidemiologic study of breast cancer
N W Choi, G R Howe, A B Miller, et al.
Antiviral Therapy
|
September 14, 2010
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand
Anchalee Avihingsanon, Sharon R Lewin, Stephen Kerr, et al.
AIDS (London, England)
|
November 16, 2010
Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression
David M Iser, Anchalee Avihingsanon, Naruemon Wisedopas, et al.
Hepatology (Baltimore, Md.)
|
September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study
Marianne Martinello, Edward Gane, Margaret Hellard, et al.
Page
of 30